SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--National Resilience, Inc. (Resilience), a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics, today announced an agreement to manufacture mRNA for the Moderna COVID-19 vaccine.
Click here to read the full press release from Business Wire.
